ClinicalTrials.Veeva

Menu

Psychoeducation for Transient Ischaemic Attack and Minor Stroke (OPTIMISM)

U

University of Nottingham

Status

Completed

Conditions

Stroke
Transient Ischaemic Attack

Treatments

Behavioral: Psychoeducation

Study type

Interventional

Funder types

Other

Identifiers

NCT02550392
15079
TSA PDF 2015-01 (Other Grant/Funding Number)

Details and patient eligibility

About

Transient Ischaemic Attack (TIA), also called 'ministroke' is characterised by shortlasting symptoms that generally do not cause permanent damage. 'Minor stroke' is a term used to describe a stroke with mild and nondisabling symptoms. TIA and minor stroke patients account for more than half of all cases of stroke and they are at a higher risk to suffer a major stroke. Currently, management of TIA/minor stroke patients is mainly focused on identifying and reducing risk factors for a later stroke. However, people after a TIA often have limited access for further specialist support from stroke-specific rehabilitation services. Although there is variability in the level of recovery and severity of symptoms after TIA and minor stroke, there is evidence that these patients may experience difficulties that affect their quality of life including anxiety and depression.

This study aims to develop, tailor and target the delivery of a time-limited group intervention that offers educational, psychological and social support for people following TIA and minor stroke. A qualitative study (Phase 1) will be conducted with service users and experts working with people with TIA/minor stroke to develop the psychoeducational intervention. Following this, we will conduct a feasibility randomised controlled trial in one centre (Phase 2) to explore whether this group psychoeducational intervention for people after TIA and minor stroke carers is acceptable and to determine the feasibility of the proposed evaluation and the sample size needed in a definite trial.

Full description

Participants will complete measures at baseline and then randomly allocated to receive the intervention or usual care. The intervention group will receive a group psychoeducational intervention (designed in Phase 1: Qualitative study) in addition to self-help leaflets and usual care. It is anticipated that the intervention will be offered in 6 two-hour sessions over 3 months by an assistant psychologist. The control group will receive usual care plus self-help leaflets on relevant topics. All participants will complete outcome measures at 3 and 6 months after randomisation. We will test the feasibility, tolerability and acceptability of delivering the intervention and will record data on study completion and attrition. Findings will inform the development of a larger trial and will determine if the content and delivery of the intervention meets the needs of people after TIA and minor stroke.

Enrollment

64 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults with a first/recurrent TIA or minor stroke;
  • identified within 6 months of their diagnosis;
  • who are independent with activities of daily living;
  • who consent to take part

Exclusion criteria

  • diagnosis of dementia;
  • receiving psychological interventions for mental health difficulties immediately prior to their TIA/minor stroke, visual or hearing impairments that would impact on ability to complete baseline assessments;
  • cognitive or communication difficulties that would impact on ability to complete baseline assessments and to participate in group sessions;
  • unable to communicate in English.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

64 participants in 2 patient groups

Group psychoeducation
Experimental group
Description:
The intervention group will receive a group psychoeducational intervention (designed in Phase 1: Qualitative study) and usual care.
Treatment:
Behavioral: Psychoeducation
Control group
No Intervention group
Description:
Participants in the usual care control group will continue to receive all other services routinely available to them as is usual practice.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems